Anúncio
Anúncio
CASI
CASI Pharmaceuticals, Inc. Ordinary Shares
1.08
USDPatrocinado
+0.02
+1.88%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
1.09
+0.01
+0.92%
Relatórios de Lucros CASI
Rácio de surpresa positiva
CASI separação 19 de 36 últimas estimativas.
53%
Próximo Relatório
Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.36
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-100.00%
/-46.27%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/--
CASI Pharmaceuticals, Inc. Ordinary Shares earnings per share and revenue
On 14 de nov. de 2025, CASI reported earnings of -0.67 USD per share (EPS) for Q3 25, missing the estimate of -0.40 USD, resulting in a -64.22% surprise. Revenue reached 3.08 milhão, compared to an expected --, with a 0.00% difference. The market reacted with a -5.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.36 USD, with revenue projected to reach -- USD, implying an diminuir of -46.27% EPS, and diminuir of -100.00% in Revenue from the last quarter.
FAQ
What were CASI Pharmaceuticals, Inc. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CASI Pharmaceuticals, Inc. Ordinary Shares reported EPS of -$0.67, missing estimates by -64.22%, and revenue of $3.08M, 0% as expectations.
How did the market react to CASI Pharmaceuticals, Inc. Ordinary Shares's Q3 2025 earnings?
The stock price moved down -5.56%, changed from $1.26 before the earnings release to $1.19 the day after.
When is CASI Pharmaceuticals, Inc. Ordinary Shares expected to report next?
The next earning report is scheduled for 30 de mar. de 2026.
What are the forecasts for CASI Pharmaceuticals, Inc. Ordinary Shares's next earnings report?
Based on 3
analistas, CASI Pharmaceuticals, Inc. Ordinary Shares is expected to report EPS of -$0.36 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio